T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$6.08B |
| 2 |
PayPal
PYPL
|
+$722M |
| 3 |
JNPR
Juniper Networks
JNPR
|
+$712M |
| 4 |
FITB
Fifth Third Bancorp
FITB
|
+$692M |
| 5 |
Morgan Stanley
MS
|
+$644M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class C
GOOG
|
+$5.54B |
| 2 |
Vipshop
VIPS
|
+$825M |
| 3 |
Honeywell
HON
|
+$813M |
| 4 |
Estee Lauder
EL
|
+$804M |
| 5 |
GE Aerospace
GE
|
+$787M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 22.49% |
| 2 | Consumer Discretionary | 15.06% |
| 3 | Financials | 13.94% |
| 4 | Technology | 11.82% |
| 5 | Industrials | 9.68% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
Bristol-Myers Squibb
BMY
$130B
| $3.36B | 0.71% |
48,810,372
+6,881,745
| +16% | +$455M |
|
27
American Tower
AMT
$79B
| $3.32B | 0.7% |
34,281,860
+1,888,736
| +6% | +$184M |
|
|
CELG
28
DELISTED
Celgene Corp
CELG
| $3.15B | 0.66% |
26,275,938
-1,895,528
| -7% | -$219M |
|
29
McKesson
MCK
$105B
| $3.01B | 0.63% |
15,245,750
-1,828,758
| -11% | -$345M |
|
|
FISV
30
Fiserv Inc
FISV
$28B
| $2.86B | 0.6% |
62,506,454
-11,411,002
| -15% | -$536M |
|
31
Roper Technologies
ROP
$39.5B
| $2.78B | 0.59% |
14,666,657
-121,669
| -0.8% | -$22.3M |
|
32
Intercontinental Exchange
ICE
$84.9B
| $2.73B | 0.57% |
53,308,445
+3,953,725
| +8% | +$199M |
|
33
ExxonMobil
XOM
$657B
| $2.71B | 0.57% |
34,763,926
+4,267,723
| +14% | +$341M |
|
34
AutoZone
AZO
$49.7B
| $2.66B | 0.56% |
3,581,920
-365,751
| -9% | -$279M |
|
35
Becton Dickinson
BDX
$49.4B
| $2.61B | 0.55% |
17,353,018
+95,835
| +0.6% | +$13.8M |
|
36
Regeneron Pharmaceuticals
REGN
$82.1B
| $2.57B | 0.54% |
4,738,293
-59,862
| -1% | -$32.4M |
|
37
Walt Disney
DIS
$179B
| $2.52B | 0.53% |
23,956,048
-274,724
| -1% | -$30.6M |
|
38
Salesforce
CRM
$162B
| $2.41B | 0.51% |
30,686,091
-8,558,705
| -22% | -$668M |
|
39
PG&E
PCG
$38.1B
| $2.38B | 0.5% |
44,704,143
+4,252,203
| +11% | +$226M |
|
40
Vertex Pharmaceuticals
VRTX
$134B
| $2.37B | 0.5% |
18,823,471
+3,832,331
| +26% | +$463M |
|
|
BNY
41
Bank of New York Mellon
BNY
$109B
| $2.35B | 0.49% |
56,913,143
-4,135,093
| -7% | -$174M |
|
42
Citigroup
C
$228B
| $2.26B | 0.48% |
43,715,913
+9,385,298
| +27% | +$498M |
|
43
Bausch Health
BHC
$2.33B
| $2.22B | 0.47% |
21,853,814
+1,806,903
| +9% | +$203M |
|
44
Philip Morris
PM
$290B
| $2.16B | 0.46% |
24,610,930
+2,903,792
| +13% | +$252M |
|
|
LNKD
45
DELISTED
LinkedIn Corporation
LNKD
| $2.12B | 0.45% |
9,410,966
-661,075
| -7% | -$150M |
|
|
AET
46
DELISTED
Aetna Inc
AET
| $2.08B | 0.44% |
19,210,001
+2,385,631
| +14% | +$258M |
|
47
Incyte
INCY
$24.5B
| $2.07B | 0.43% |
19,059,471
-143,425
| -0.7% | -$16M |
|
48
Starbucks
SBUX
$122B
| $2B | 0.42% |
33,329,782
-5,093,291
| -13% | -$310M |
|
49
Nike
NKE
$61.3B
| $1.98B | 0.42% |
31,756,682
+4,409,586
| +16% | +$284M |
|
50
Johnson & Johnson
JNJ
$626B
| $1.98B | 0.42% |
19,281,059
-1,100,417
| -5% | -$111M |
|
Similar funds
T. Rowe Price Associates's Q4 2015 Portfolio in Review
As of Q4 2015, T. Rowe Price Associates held 2,616 positions worth $475B, up 5.8% from $449B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
T. Rowe Price Associates's Q4 2015 filing shows 108 new, 1,286 increased, 995 reduced and 102 closed positions. Its largest new stake was Alphabet (Google) Class A: 164,207,340 shares worth $6.39B. The largest sale was Alphabet (Google) Class C, an estimated $5.54B.
By sector, the portfolio is most concentrated in Healthcare at 22% of assets, up from 22% a quarter earlier, followed by Consumer Discretionary and Financials.
- T. Rowe Price Associates's largest Q4 2015 buy was Alphabet (Google) Class A: 164,207,340 shares worth $6.39B.
- T. Rowe Price Associates added most to PayPal in Q4 2015, an estimated $722M increase.
- T. Rowe Price Associates's biggest Q4 2015 reduction was Alphabet (Google) Class C, cutting an estimated $5.54B.
- T. Rowe Price Associates fully exited CYTEC INDS INC in Q4 2015, selling an estimated $610M.
- T. Rowe Price Associates's ten largest holdings make up 16% of its $475B portfolio in Q4 2015.
- T. Rowe Price Associates opened 108 new positions and closed 102 in Q4 2015.
- T. Rowe Price Associates's portfolio value rose 5.8% quarter-over-quarter to $475B.
Based on T. Rowe Price Associates's 13F filing for Q4 2015, filed 16 Feb 2016.